RecruitingNCT06507865

Post Market Registry for GORE® TAG® Thoracic Branch Endoprosthesis

Characterization of Mid-term Post Market Clinical Follow Up of GORE® TAG® Thoracic Branch Endoprosthesis Facilitated Aortic Arch and Descending Aorta Intervention

Sponsor

W.L.Gore & Associates

Enrollment

200 participants

Start Date

Feb 20, 2025

Study Type

OBSERVATIONAL

Conditions

Thoracic Aortic Aneurysm Aneurysm Dissection, Aortic Transection Aorta TAA Thoracoabdominal Aortic Aneurysm

Summary

The goal of this observational study is to collect mid-term post-market clinical follow-up data of GORE® TAG® Thoracic Branch Endoprosthesis used according to the standard medical practice in patients presenting with vascular disease. This registry aims to answer questions related to the efficacy and safety of GORE® TAG® Thoracic Branch Endoprosthesis.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called GORE® TAG® Thoracic Branch Endoprosthesis for people with aneurysm, dissection, aortic, and other related conditions. The study is currently recruiting participants at 20 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEGORE® TAG® Thoracic Branch Endoprosthesis

Patients presenting with thoracic vascular disease that may benefit from the placement of TBE device. The target registry population is patients who are treated with TBE at participating sites. TBE treatment is qualified as receiving the TBE aortic component, at a minimum.

Locations(20)

Medizinische Universität Wien

Vienna, Austria

Rigshospitalet University Hospital

Copenhagen, Denmark

Universitätsklinikum Carl Gustav Carus Dresden

Dresden, Germany

University of Heidelberg

Heidelberg, Germany

Universitätsklinikum Schleswig-Holstein

Kiel, Germany

Universitätsklinikum Münster

Münster, Germany

Evangelismos General Hospital

Athens, Greece

Laiko General hospital of Athens

Athens, Greece

Policlinico di Sant'Orsola

Bologna, Italy

ASST Spedali Civili di Brescia

Brescia, Italy

IRCCS Ospedale Policlinico San Martino

Genova, Italy

AOU Padova

Padova, Italy

Azienda Ospedaliera "G. Brotzu"

Selargius, Italy

Amsterdam UMC

Amsterdam, Netherlands

Radboud UMC

Nijmegen, Netherlands

Complejo Hospitalario Universitario de Vigo

Vigo, Spain

Hospital Universitario Miguel Servet

Zaragoza, Spain

Skane University Hospital

Malmö, Sweden

St Thomas' Hospital

London, United Kingdom

St Mary's Hospital

London, United Kingdom

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06507865

Related Trials

Individual Patient Data Meta-Analysis of Prospective Studies of Patients Treated With the GORE® Iliac Branched Endoprosthesis

NCT077046711 location

Long-term Characterization of GORE® TAG® Conformable Thoracic Stent Graft With ACTIVE CONTROL System Performance

NCT0665873036 locations